Prestige Consumer Healthcare Inc.

NYSE:PBH

Medical - Distribution

Healthcare
$50.62 +0.49%

+$0.23 today

Market cap
$2.40B
Beta
0.35
P/E (TTM)
11.6
EPS (TTM)
$4.01
52W Low $42.62High $85.29

Volume 0.62M

Average 0.67M

PBH Accounts Receivables

Cash effect of the change in amounts owed by customers; growing receivables consume cash.

Prestige Consumer Healthcare Inc.NYSE: PBH

Accounts Receivables · Q1 FY2027 · quarter ended Jun 2026

Accounts receivables declines year over year

Q1 FY2027 accounts receivables of $3.45M fell 87.4% year over year, ahead of the -693.3% change in trailing-twelve-month accounts receivables. Over 3 fiscal years it compounded at -47.1% a year.

Context

  • Accounts receivables amounted to 0.3% of revenue in FY2026, down 1.1 pp from a year earlier.
  • Accounts receivables grew in size in 1 of the last 3 fiscal years.
  • FY2026 was the smallest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of -87.4% holds above the trailing-twelve-month pace of -693.3%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterJun 2026
$3.45M+315.6% QoQ
Last fiscal yearMar 2026
-$3.69M-77.4% YoY
LTMJun 2026
-$27.58M-693.3% YoY
Accounts Receivables past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-87.4%——
1 year-77.4%——
3-year CAGR-47.1%——
5-year CAGR——
10-year CAGR——

Accounts Receivables history

USD · from the cash flow

Latest · FY2026
(3.69M) USD
Year-over-year change
+77.4%

Accounts Receivables vs competitors

How PBH compares with its peers on the latest reported figures

  • PBH's LTM Jun 2026 accounts receivables of $27.58M is the 5th largest of the 11 companies compared; the peer median is $24.58M.
  • Its year-over-year change of -693.3% is the lowest of 10, against a peer median of +179.5%.
  • Accounts receivables amounts to 2.5% of revenue for PBH, versus a peer median of 3.7%.
PBH Competitors Peer median
Accounts Receivables for PBH and competitors
Company Period LTM YoY 3-year CAGR% of revenue
LEGNLegend Biotech CorporationLTM Sep 2026$125.44M +174128.2%—9.2%
PRVAPrivia Health Group, Inc.LTM Jun 2026$87.55M +41.1%-20.2%3.7%
CPRXCatalyst Pharmaceuticals, Inc.LTM Mar 2026$59.57M +453.0%+151.8%10.0%
CONConcentra Group Holdings Parent, Inc.LTM Sep 2026$28.63M +47.8%+23.4%1.2%
PBHPrestige Consumer Healthcare Inc.LTM Jun 2026$27.58M -693.3%-47.1%2.5%
LIVNLivaNova PLCLTM Sep 2026$27.33M +124.1%+30.6%1.8%
ZLABZai Lab LimitedLTM Jun 2026$26.3M +212.9%—5.8%
ATECAlphatec Holdings, Inc.LTM Mar 2026$21.84M +179.5%+5.1%2.8%
HTFLHeartflow, Inc. Common StockLTM Sep 2026$20.7M +374.9%—8.7%
ICUIICU Medical, Inc.LTM Jun 2026$15.38M -58.3%—0.7%
IRONDisc Medicine, Inc.LTM Sep 2026$0 ———
Peer median (excluding PBH) $24.58M+179.5%+23.4%3.7%

Competitors are the stored peer set for PBH. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2022
Mar 2022
FY2023
Mar 2023
FY2024
Mar 2024
FY2025
Mar 2025
FY2026
Mar 2026
Net Income205.38M(82.31M)209.34M214.61M190.3M
Depreciation & Amortization32.09M32.63M30.68M30.17M31.27M
Deferred Income Tax9.98M(60.77M)23.07M14.41M22.7M
Stock-Based Compensation9.04M12.41M14.01M11.16M10.84M
Change in Working Capital(10.95M)(53.86M)(39.83M)(41.94M)(17.62M)
Accounts Receivables(24.65M)(24.93M)(6.32M)(16.33M)(3.69M)
Inventory663K(42.23M)24.44M(9.31M)(1.6M)
Accounts Payables9.15M7.26M(24.97M)(19.41M)(151K)
Other Working Capital3.89M6.04M(32.98M)3.11M(12.19M)
Other Non-Cash Items14.38M381.61M11.66M23.11M20.14M
Operating Cash Flow259.92M229.72M248.93M251.52M257.63M
Capital Expenditures(9.64M)(7.78M)(9.55M)(8.22M)(11.18M)
Acquisitions (Net)(246.87M)(3.8M)(10.56M)(9.23M)(123.74M)
Purchases of Investments00000
Sales of Investments00000
Other Investing Activities0000(1.93M)
Investing Cash Flow(256.51M)(11.58M)(20.11M)(17.45M)(136.84M)
Debt Repayment(5.58M)(137.75M)(227.83M)(139.54M)504K
Common Stock Issued7.04M0014.8M4.29M
Common Stock Repurchased0(50M)(25M)(51.51M)(156.28M)
Dividends Paid00000
Other Financing Activities(9.03M)1.91M11.81M(5.83M)(4.57M)
Financing Cash Flow(7.57M)(185.85M)(241.02M)(182.08M)(156.06M)
Effect of Forex Changes(959K)(982K)180K(573K)1.26M
Net Change in Cash(5.12M)31.3M(12.02M)51.42M(34.02M)
Free Cash Flow250.28M221.93M239.38M243.29M246.45M

Prestige Consumer Healthcare Inc.

NYSE:PBH

Intrinsic Alpha fair value

Locked

Current Price

$50.62

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.